Literature DB >> 2011496

Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.

W E Hopkins1, D R Westerhausen, B E Sobel, J J Billadello.   

Abstract

Secretion of plasminogen activator inhibitor type-1 (PAI-1) by cultured cells is increased after exposure to specific cytokines and growth factors. We have shown previously that incubation of Hep G2 cells with epidermal growth factor (EGF) results in a marked increase in steady state levels of PAI-1 mRNA (Lucore, C.L., et al. (1988) J. Biol. Chem. 263, 15845-15848). The present study was undertaken to determine whether the regulation of expression of PAI-1 mRNA by EGF is mediated at the level of transcription and/or by post-transcriptional mechanisms. The rate of transcription of the PAI-1 gene measured by nuclear run-on assays was found to be increased within 2 h after stimulation of the cells with EGF (5 ng/ml) (3.2 fold increase relative to control, n = 2, range 3.0-3.4). It reached a maximum in 3 h, (9.2 fold increase relative to control, n = 2, range 8.8-9.6) and returned to baseline in 5 h. Exposure of the cells to EGF did not increase the rate of transcription of the glyceraldehyde-3-phosphate dehydrogenase gene. The half life of PAI-1 mRNA in Hep G2 cells was 120 min as determined by RNA blot analysis after exposure of the cells to actinomycin D to inhibit transcription. Stimulation of the cells with EGF did not result in significant change in the half life of PAI-1 mRNA. The results demonstrate that exposure of Hep G2 cells to EGF increases PAI-1 gene transcription.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011496      PMCID: PMC333547          DOI: 10.1093/nar/19.1.163

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.

Authors:  D J Loskutoff; K Roegner; L A Erickson; R R Schleef; A Huttenlocher; P L Coleman; T D Gelehrter
Journal:  Thromb Haemost       Date:  1986-02-28       Impact factor: 5.249

2.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease.

Authors:  L F Engebretsen; P Kierulf; P Brandtzaeg
Journal:  Thromb Res       Date:  1986-06-01       Impact factor: 3.944

4.  Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

Authors:  L A Erickson; M H Ginsberg; D J Loskutoff
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.

Authors:  E D Sprengers; H M Princen; T Kooistra; V W van Hinsbergh
Journal:  J Lab Clin Med       Date:  1985-06

7.  Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

Authors:  M Colucci; J A Paramo; D Collen
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.

Authors:  C Kluft; J H Verheijen; A F Jie; D C Rijken; F E Preston; H M Sue-Ling; J Jespersen; A O Aasen
Journal:  Scand J Clin Lab Invest       Date:  1985-11       Impact factor: 1.713

10.  Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.

Authors:  T Ny; L Bjersing; A J Hsueh; D J Loskutoff
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

View more
  5 in total

1.  Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.

Authors:  D J Schneider; B E Sobel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

2.  Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.

Authors:  P G Fattal; J J Billadello
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

3.  EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Steven W Paugh; Lauren Bryan; Dmitri Kapitonov; Katarzyna M Wilczynska; Sunita M Gopalan; Hanna Rokita; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  FASEB J       Date:  2007-09-12       Impact factor: 5.191

4.  Cell-shape-dependent modulation of p52(PAI-1) gene expression involves a secondary response pathway.

Authors:  P J Higgins; L Staiano-Coico; M P Ryan
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

5.  Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion.

Authors:  M P Ryan; S M Kutz; P J Higgins
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.